Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ABEO
#3373
Abeona Therapeutics Inc. Common Stock
5.1
9
USD
+2.57%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.57%
Monthly Change
+9.03%
6 month change
-2.99%
Year Change
+4.64%
Previous Close
5.0
6
Open
5.1
9
Bid
Ask
Low
5.1
9
High
5.1
9
Volume
44
Markets
US Stock Market
Healthcare
ABEO
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
3.95 M
5.9 M
17.71 M
27.36 M
48.53 M
57.05 M
—
Valuation ratios
Enterprise value
144.26 M
16.73 M
36.43 M
146.78 M
265.94 M
242.25 M
859.39 M
Price to earnings ratio
—
—
-0.52
-2.19
-3.59
5.22
4.72
Price to sales ratio
—
—
15.9
33.78
—
59.89
—
Price to cash flow ratio
—
—
-0.52
-3.19
-4.08
-4.57
-16.29
Price to book ratio
—
—
0.84
7.97
5.19
2.19
5.07
Enterprise value to EBITDA ratio
-1.97
-0.3
-0.76
-3.27
-4.25
-2.7
-11.02
Profitability ratios
Return on assets %
-0.56
-1.07
-0.62
-0.85
-0.59
0.32
0.21
Return on equity %
-0.82
-1.65
-1.48
-3.65
-1.45
0.45
0.22
Return on invested capital %
-313.61
-607.99
-925.94
-1 399.91
-1 787.67
-1 670.79
-1 161.91
Gross margin %
100
100
100
100
—
73.68
—
Operating margin %
-814.2
-2 994.53
-3 600.78
-1 346.71
—
-1 536.91
—
EBITDA margin %
-768.34
-2 886.2
-3 382.04
-1 281.34
—
-1 493.11
—
Net margin %
-842.34
-2 831.2
-2 807.36
-1 548.23
—
1 223.08
—
Liquidity ratios
Quick ratio
—
—
—
—
—
6.74
—
Current ratio
2.33
3.33
6.83
4.15
6.08
6.93
28.3
Inventory turnover
—
—
—
—
—
0.56
—
Asset turnover
0.05
0.03
0.02
0.05
0
0.04
0.03
Solvency ratios
Debt to assets ratio
0.01
0
—
0.16
0.17
0.09
0.45
Debt to equity ratio
0.02
0
—
0.67
0.43
0.13
0.83
Long term debt to total assets ratio
0.01
0
—
0.07
0.12
0.04
0.25
Long term debt to total equity ratio
0.02
0
—
0.31
0.3
0.05
0.47
Per share metrics
Operating cash flow per share
—
—
-5.53
-1.73
-1.36
-1.15
-1.31
EBIT per share
—
—
-6.48
-2.2
-1.56
-1.35
-1.53
EBITDA per share
—
—
-6.08
-2.1
-1.52
-1.31
-1.48
Total debt per share
—
—
—
0.47
0.46
0.3
1.35
Cash per share
—
—
6.68
2.46
2.39
2.89
11.79
Net current asset value per share
—
—
6.75
2.61
2.46
3.1
12.34
Tangible book value per share
—
—
3.23
0.69
1.07
2.41
8.85
Working capital per share
—
—
5.76
1.98
2.05
2.65
10.6
Book value per share
—
—
3.4
0.69
1.07
2.41
8.85
News
Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point (NASDAQ:ABEO)
Abeona Therapeutics CFO Vazzano sells $3.7k in stock
Oppenheimer raises Abeona Therapeutics price target on launch progress
Abeona reports progress in ZEVASKYN gene therapy launch
3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts - TipRanks.com
Abeona Therapeutics director sells $75k in stock
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895
Cantor Fitzgerald reiterates Overweight rating on Abeona Therapeutics stock
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer
University of Texas Medical Branch activated as treatment center for RDEB therapy
Stifel lowers Abeona Therapeutics stock price target on launch delay
Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript